Cargando…
The Extraglycemic Effect of SGLT-2is on Mineral and Bone Metabolism and Bone Fracture
Type 2 diabetes mellitus (T2DM) is a risk factor for osteoporosis. The effects of T2DM and anti-diabetic agents on bone and mineral metabolism have been observed. Sodium–glucose co-transporter 2 inhibitors (SGLT-2is) promote urinary glucose excretion, reduce blood glucose level, and improve the card...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302585/ https://www.ncbi.nlm.nih.gov/pubmed/35872985 http://dx.doi.org/10.3389/fendo.2022.918350 |
_version_ | 1784751662863220736 |
---|---|
author | Dong, Bingzi Lv, Ruolin Wang, Jun Che, Lin Wang, Zhongchao Huai, Zhouyang Wang, Yangang Xu, Lili |
author_facet | Dong, Bingzi Lv, Ruolin Wang, Jun Che, Lin Wang, Zhongchao Huai, Zhouyang Wang, Yangang Xu, Lili |
author_sort | Dong, Bingzi |
collection | PubMed |
description | Type 2 diabetes mellitus (T2DM) is a risk factor for osteoporosis. The effects of T2DM and anti-diabetic agents on bone and mineral metabolism have been observed. Sodium–glucose co-transporter 2 inhibitors (SGLT-2is) promote urinary glucose excretion, reduce blood glucose level, and improve the cardiovascular and diabetic nephropathy outcomes. In this review, we focused on the extraglycemic effect and physiological regulation of SGLT-2is on bone and mineral metabolism. SGLT-2is affect the bone turnover, microarchitecture, and bone strength indirectly. Clinical evidence of a meta-analysis showed that SGLT-2is might not increase the risk of bone fracture. The effect of SGLT-2is on bone fracture is controversial, and further investigation from a real-world study is needed. Based on its significant benefit on cardiovascular and chronic kidney disease (CKD) outcomes, SGLT-2is are an outstanding choice. Bone mineral density (BMD) and fracture risk evaluation should be considered for patients with a high risk of bone fracture. |
format | Online Article Text |
id | pubmed-9302585 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93025852022-07-22 The Extraglycemic Effect of SGLT-2is on Mineral and Bone Metabolism and Bone Fracture Dong, Bingzi Lv, Ruolin Wang, Jun Che, Lin Wang, Zhongchao Huai, Zhouyang Wang, Yangang Xu, Lili Front Endocrinol (Lausanne) Endocrinology Type 2 diabetes mellitus (T2DM) is a risk factor for osteoporosis. The effects of T2DM and anti-diabetic agents on bone and mineral metabolism have been observed. Sodium–glucose co-transporter 2 inhibitors (SGLT-2is) promote urinary glucose excretion, reduce blood glucose level, and improve the cardiovascular and diabetic nephropathy outcomes. In this review, we focused on the extraglycemic effect and physiological regulation of SGLT-2is on bone and mineral metabolism. SGLT-2is affect the bone turnover, microarchitecture, and bone strength indirectly. Clinical evidence of a meta-analysis showed that SGLT-2is might not increase the risk of bone fracture. The effect of SGLT-2is on bone fracture is controversial, and further investigation from a real-world study is needed. Based on its significant benefit on cardiovascular and chronic kidney disease (CKD) outcomes, SGLT-2is are an outstanding choice. Bone mineral density (BMD) and fracture risk evaluation should be considered for patients with a high risk of bone fracture. Frontiers Media S.A. 2022-07-07 /pmc/articles/PMC9302585/ /pubmed/35872985 http://dx.doi.org/10.3389/fendo.2022.918350 Text en Copyright © 2022 Dong, Lv, Wang, Che, Wang, Huai, Wang and Xu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology Dong, Bingzi Lv, Ruolin Wang, Jun Che, Lin Wang, Zhongchao Huai, Zhouyang Wang, Yangang Xu, Lili The Extraglycemic Effect of SGLT-2is on Mineral and Bone Metabolism and Bone Fracture |
title | The Extraglycemic Effect of SGLT-2is on Mineral and Bone Metabolism and Bone Fracture |
title_full | The Extraglycemic Effect of SGLT-2is on Mineral and Bone Metabolism and Bone Fracture |
title_fullStr | The Extraglycemic Effect of SGLT-2is on Mineral and Bone Metabolism and Bone Fracture |
title_full_unstemmed | The Extraglycemic Effect of SGLT-2is on Mineral and Bone Metabolism and Bone Fracture |
title_short | The Extraglycemic Effect of SGLT-2is on Mineral and Bone Metabolism and Bone Fracture |
title_sort | extraglycemic effect of sglt-2is on mineral and bone metabolism and bone fracture |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302585/ https://www.ncbi.nlm.nih.gov/pubmed/35872985 http://dx.doi.org/10.3389/fendo.2022.918350 |
work_keys_str_mv | AT dongbingzi theextraglycemiceffectofsglt2isonmineralandbonemetabolismandbonefracture AT lvruolin theextraglycemiceffectofsglt2isonmineralandbonemetabolismandbonefracture AT wangjun theextraglycemiceffectofsglt2isonmineralandbonemetabolismandbonefracture AT chelin theextraglycemiceffectofsglt2isonmineralandbonemetabolismandbonefracture AT wangzhongchao theextraglycemiceffectofsglt2isonmineralandbonemetabolismandbonefracture AT huaizhouyang theextraglycemiceffectofsglt2isonmineralandbonemetabolismandbonefracture AT wangyangang theextraglycemiceffectofsglt2isonmineralandbonemetabolismandbonefracture AT xulili theextraglycemiceffectofsglt2isonmineralandbonemetabolismandbonefracture AT dongbingzi extraglycemiceffectofsglt2isonmineralandbonemetabolismandbonefracture AT lvruolin extraglycemiceffectofsglt2isonmineralandbonemetabolismandbonefracture AT wangjun extraglycemiceffectofsglt2isonmineralandbonemetabolismandbonefracture AT chelin extraglycemiceffectofsglt2isonmineralandbonemetabolismandbonefracture AT wangzhongchao extraglycemiceffectofsglt2isonmineralandbonemetabolismandbonefracture AT huaizhouyang extraglycemiceffectofsglt2isonmineralandbonemetabolismandbonefracture AT wangyangang extraglycemiceffectofsglt2isonmineralandbonemetabolismandbonefracture AT xulili extraglycemiceffectofsglt2isonmineralandbonemetabolismandbonefracture |